121 related articles for article (PubMed ID: 38049248)
21. Percutaneous radiofrequency ablation of renal tumors: midterm results in 16 patients.
Memarsadeghi M; Schmook T; Remzi M; Weber M; Pötscher G; Lammer J; Kettenbach J
Eur J Radiol; 2006 Aug; 59(2):183-9. PubMed ID: 16725292
[TBL] [Abstract][Full Text] [Related]
22. Percutaneous radiofrequency ablation of renal cell carcinoma.
Chiou YY; Hwang JI; Chou YH; Wang JH; Chiang JH; Chang CY
J Chin Med Assoc; 2005 May; 68(5):221-5. PubMed ID: 15909727
[TBL] [Abstract][Full Text] [Related]
23. Percutaneous microwave ablation of T1a and T1b renal cell carcinoma: short-term efficacy and complications with emphasis on tumor complexity and single session treatment.
Wells SA; Wheeler KM; Mithqal A; Patel MS; Brace CL; Schenkman NS
Abdom Radiol (NY); 2016 Jun; 41(6):1203-11. PubMed ID: 27167230
[TBL] [Abstract][Full Text] [Related]
24. [Long-term effects of ultrasound-guided microwave ablation in the treatment of small renal cell carcinoma].
Mu MJ; Yu J; Liang P; Yu XL; Han ZY; Cheng ZG; Liu FY; Zhai HY; Li X
Nan Fang Yi Ke Da Xue Xue Bao; 2016 May; 36(5):622-7. PubMed ID: 27222174
[TBL] [Abstract][Full Text] [Related]
25. Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center.
Zhou W; Uppot RN; Feldman AS; Arellano RS
AJR Am J Roentgenol; 2017 Oct; 209(4):733-739. PubMed ID: 28678572
[TBL] [Abstract][Full Text] [Related]
26. Percutaneous radiofrequency ablation of renal tumors in high-risk patients: 10 years' experience.
Alguersuari A; Mateos A; Falcó J; Criado E; Fortuño JR; Guitart J
Radiologia; 2016; 58(5):373-9. PubMed ID: 27264790
[TBL] [Abstract][Full Text] [Related]
27. Simultaneous biopsy and radiofrequency ablation of T1a renal cell carcinoma.
Iguchi T; Hiraki T; Tomita K; Gobara H; Fujiwara H; Sakurai J; Matsui Y; Kanazawa S
Diagn Interv Imaging; 2016 Nov; 97(11):1159-1164. PubMed ID: 27256108
[TBL] [Abstract][Full Text] [Related]
28. A multicenter 10-year oncologic outcome of ultrasound-guided percutaneous microwave ablation of clinical T1 renal cell carcinoma: will it stand the test of time?
Yu J; Wang H; Cheng ZG; Liu FY; Li QY; He GZ; Luo YC; Yu XL; Han ZY; Liang P
Eur Radiol; 2022 Jan; 32(1):89-100. PubMed ID: 34195888
[TBL] [Abstract][Full Text] [Related]
29. Image-Guided Thermal Ablation for Non-resectable Recurrence of Renal Cell Cancer Following Nephrectomy: Clinical Experience with Eleven Patients.
Zhou W; Herwald SE; Uppot RN; Arellano RS
Cardiovasc Intervent Radiol; 2018 Nov; 41(11):1743-1750. PubMed ID: 29721615
[TBL] [Abstract][Full Text] [Related]
30. Intermediate outcomes and predictors of efficacy in the radiofrequency ablation of 100 pathologically proven renal cell carcinomas.
McClure TD; Chow DS; Tan N; Sayre JA; Pantuck AJ; Raman SS
J Vasc Interv Radiol; 2014 Nov; 25(11):1682-8; quiz 1689. PubMed ID: 25081202
[TBL] [Abstract][Full Text] [Related]
31. [Percutaneous CT-guided radiofrequency ablation for small renal masses : A retrospective, single center data analysis].
Heißler O; Seklehner S; Fellner H; Engelhardt PF; Chemelli A; Riedl C
Urologe A; 2018 Jul; 57(7):828-835. PubMed ID: 29797025
[TBL] [Abstract][Full Text] [Related]
32. Radiofrequency ablation of renal cell carcinoma: part 2, Lessons learned with ablation of 100 tumors.
Gervais DA; Arellano RS; McGovern FJ; McDougal WS; Mueller PR
AJR Am J Roentgenol; 2005 Jul; 185(1):72-80. PubMed ID: 15972401
[TBL] [Abstract][Full Text] [Related]
33. Percutaneous radiofrequency ablation of renal tumors in solitary kidney patients.
Jiménez E; Zurera L; Espejo JJ; Requena MJ; Campos P; Rodríguez de Tembleque L; Canis M
Arch Esp Urol; 2011; 64(1):51-8. PubMed ID: 21289386
[TBL] [Abstract][Full Text] [Related]
34. Percutaneous radiofrequency ablation of renal cell carcinoma: preliminary results.
Mahnken AH; Rohde D; Brkovic D; Günther RW; Tacke JA
Acta Radiol; 2005 Apr; 46(2):208-14. PubMed ID: 15902899
[TBL] [Abstract][Full Text] [Related]
35. Percutaneous radiofrequency ablation of renal cell carcinoma.
Gervais DA; Arellano RS; Mueller PR
Eur Radiol; 2005 May; 15(5):960-7. PubMed ID: 15756553
[TBL] [Abstract][Full Text] [Related]
36. Percutaneous radio frequency ablation of renal tumors in patients with von Hippel-Lindau disease: preliminary results.
Park BK; Kim CK
J Urol; 2010 May; 183(5):1703-7. PubMed ID: 20299060
[TBL] [Abstract][Full Text] [Related]
37. Percutaneous radiofrequency ablation of sporadic Bosniak III or IV lesions: treatment techniques and short-term outcomes.
Park JJ; Park BK; Park SY; Kim CK
J Vasc Interv Radiol; 2015 Jan; 26(1):46-54. PubMed ID: 25446421
[TBL] [Abstract][Full Text] [Related]
38. Percutaneous image-guided renal ablations: Current evidences for long-term oncologic efficacy.
Nouri-Neuville M; Ben Ammar M; Cornelis FH
Presse Med; 2019; 48(7-8 Pt 2):e233-e243. PubMed ID: 31445699
[TBL] [Abstract][Full Text] [Related]
39. Percutaneous radio frequency ablation of small renal tumors: initial results.
Pavlovich CP; Walther M; Choyke PL; Pautler SE; Chang R; Linehan WM; Wood BJ
J Urol; 2002 Jan; 167(1):10-5. PubMed ID: 11743264
[TBL] [Abstract][Full Text] [Related]
40. Feasibility and oncologic control after percutaneous image guided ablation of metastatic renal cell carcinoma.
Welch BT; Callstrom MR; Morris JM; Kurup AN; Schmit GD; Weisbrod AJ; Lohse CM; Kohli M; Costello BA; Olivier KR; Thompson RH; Boorjian SA; Atwell TD
J Urol; 2014 Aug; 192(2):357-63. PubMed ID: 24631107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
